Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
Domatinostat + Avelumab for Advanced Merkel Cell Carcinoma
Recruiting1 awardPhase 2
Houston, Texas
This trial looks at how well domatinostat and avelumab work together to treat adults with advanced Merkel Cell Carcinoma that has gotten worse after previous treatment with an anti-PD-(L)1 antibody.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.